If You Haven’t Noticed Chokeberry Yet, Notice It Now!
- Cat Paquin
- Nov 28
- 2 min read

Chokeberry is a herb that has not yet attracted a lot of attention. But, as this new
study adds to the rapidly accumulating evidence for its cardiovascular benefits, it
may finally be time to pay attention.
Chokeberry shrub, or aronia, is a member of the rose family. Its berries, like so
many more famous berries, are loaded in antioxidant flavonoids: especially
anthocyanins.
Chokeberry first attracted notice in 2007 when a study found that it significantly
improved blood pressure, LDL and HDL cholesterol and triglycerides as well as
glucose, homocysteine and fibrinogen, all of which could improve heart health
(Pharmacol Rep 2007;59 (suppl 1):177-82).
The same year, chokeberry was found to improve the blood pressure lowering
effect of statin drugs in people who had survived a heart attack
(Atherosclerosis 2007;194:e179-e184).
Eight years later, another study found that chokeberry significantly improved
triglycerides and reduced both systolic and diastolic blood pressure (J Food
Med 2015;18:1231-8).
Then a study tested chokeberry on people with metabolic syndrome (MetS).
Metabolic syndrome is the constellation of any 3 of abdominal obesity, elevated
triglycerides, low HDL-cholesterol, high blood pressure and elevated blood sugar.
Chokeberry significantly improved waist size, blood sugar, systolic and diastolic
blood pressure, LDL and HDL cholesterol and triglycerides (Mol Cell Biochem.
July 2021;476(7):2663-2673).
Now, a just published study adds to the evidence. It gave either no treatment or
aronia fruit extract to 44 elderly people with metabolic syndrome. After 8 weeks,
there was significant improvement in diastolic blood pressure, triglycerides, LDL
cholesterol and small dense low-density lipoprotein. Small dense low-density
lipoprotein is an even better predictor of cardiovascular disease than LDL
cholesterol. It also significantly improved plasma atherogenic index, a ratio of
triglycerides to HDL cholesterol that is a strong predictor of the risk of
atherosclerosis and coronary heart disease.
The chokeberry extract also significantly improved markers of inflammation,
including TNF-α, IL-6 and high-sensitivity C-reactive protein as well as markers of
oxidative stress.
The study concludes that chokeberry extract “may be an effective dietary
supplement for managing MetS in high-risk groups” due to its ability to
significantly improve markers of cardiovascular health, inflammation and
oxidative stress.
J Am Nutr Assoc. 2025 Sep 4:1-10. doi:10.1080/27697061.2025.2551181.








Comments